Active Ingredient: CAPLACIZUMAB
There was no evidence for in vitro and in vivo clinically relevant ECG findings.
https://doi.org/10.1080/17512433.2019.1607293, https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/761112Orig1s000MultiR.pdf